Clinical Trials Directory

Trials / Completed

CompletedNCT03049956

OVEMP in Myasthenia

Diagnostic Accuracy of Repetitive Ocular Vestibular Evoked Myogenic Potentials in Myasthenia Gravis (OMG Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Myasthenia gravis is an autoimmune disorder of neuromuscular transmission, characterized by fluctuating muscle weakness and fatigability. In isolated ocular myasthenia, when only the extraocular muscles are involved, most common ancillary tests, such as acetylcholine receptor autoantibodies and repetitive nerve stimulation, are often negative. A simple, quick and non-invasive test for ocular myasthenia based on ocular vestibular evoked myogenic potentials (oVEMP) was recently developed. The main goal of the study is to validate repetitive oVEMP stimulation in a blinded diagnostic accuracy study in order to facilitate early and accurate diagnosis of ocular myasthenia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOcular vestibular evoced myogenic potentialsThe oVEMP technique is an accepted standard for testing otolith function in vestibular patients. It represents a quick, simple and non-invasive technique utilizing repetitive stimulation of the otolith organs with bone-conducted vibration to elicit an extraocular muscle response. Repetitive oVEMP stimulation leads to a characteristic decrement in patients with myasthenia, which can be quantified with surface electromyography from the inferior oblique muscle underneath the eye.

Timeline

Start date
2016-11-01
Primary completion
2020-12-31
First posted
2017-02-10
Last updated
2021-01-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03049956. Inclusion in this directory is not an endorsement.